Boule Diagnostics AB
Research Boule Diagnostics AB (BOUL) on Bullrun: market cap SEK 141.74M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBOUL
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Market capSEK 141.74M
- Financial periodFY2024
- RevenueSEK 558.46M
- Revenue growth-2.3%
- Net income-SEK 296.58M
- Free cash flowSEK 37.68M
- Gross margin45.2%
Valuation Snapshot
latest market cap is SEK 141.74M.
About Boule Diagnostics AB
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand.
Frequently asked questions
What is Boule Diagnostics AB's market cap?
Boule Diagnostics AB's market capitalization is SEK 141.74M.
What does Boule Diagnostics AB do?
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East.